60 related articles for article (PubMed ID: 17029274)
1. The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.
Vogt S; Schreiber S; Heinze HJ; Dengler R; Petri S; Vielhaber S
Health Qual Life Outcomes; 2019 Jun; 17(1):95. PubMed ID: 31159830
[TBL] [Abstract][Full Text] [Related]
2. Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis.
Ackrivo J; Hansen-Flaschen J; Jones BL; Wileyto EP; Schwab RJ; Elman L; Kawut SM
Am J Respir Crit Care Med; 2019 Dec; 200(12):1513-1521. PubMed ID: 31322417
[No Abstract] [Full Text] [Related]
3. Respiratory involvement in neuromuscular disease.
Bourke SC
Clin Med (Lond); 2014 Feb; 14(1):72-5. PubMed ID: 24532751
[No Abstract] [Full Text] [Related]
4. The utility of diaphragm ultrasound thickening indices for assessing respiratory decompensation in amyotrophic lateral sclerosis.
Spiliopoulos KC; Lykouras D; Veltsista D; Skaramagkas V; Karkoulias K; Tzouvelekis A; Chroni E
Muscle Nerve; 2023 Nov; 68(6):850-856. PubMed ID: 37814924
[TBL] [Abstract][Full Text] [Related]
5. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Harrower T; Orrell RW; Annadale J; Hanemann CO; Scalfari A; Tennant A; Mills R;
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Mar; ():1-11. PubMed ID: 38465877
[No Abstract] [Full Text] [Related]
6. A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosis.
Pattinson KT; Turner MR
Eur Respir J; 2016 Jun; 47(6):1632-4. PubMed ID: 27246080
[No Abstract] [Full Text] [Related]
7. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
Lechtzin N; Rothstein J; Clawson L; Diette GB; Wiener CM
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):5-13. PubMed ID: 12061943
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of respiratory muscle dysfunction in ALS.
Gregory SA
NeuroRehabilitation; 2007; 22(6):435-43. PubMed ID: 18198429
[TBL] [Abstract][Full Text] [Related]
9. Motor responses of the sternocleidomastoid muscle in patients with amyotrophic lateral sclerosis.
Pinto S; de Carvalho M
Muscle Nerve; 2008 Oct; 38(4):1312-7. PubMed ID: 18785186
[TBL] [Abstract][Full Text] [Related]
10. [Respiratory domain of revised amyotrophic lateral sclerosis. Functional Rating Scale].
Lima SE; Pessolano FA; Monteiro SG; De Vito EL
Medicina (B Aires); 2009; 69(5):547-53. PubMed ID: 19897441
[TBL] [Abstract][Full Text] [Related]
11. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
12. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
Pinto S; Pinto A; De Carvalho M
Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
[TBL] [Abstract][Full Text] [Related]
13. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.
Pinto S; Turkman A; Pinto A; Swash M; de Carvalho M
Clin Neurophysiol; 2009 May; 120(5):941-6. PubMed ID: 19342290
[TBL] [Abstract][Full Text] [Related]
14. Measures of dyspnea in patients with amyotrophic lateral sclerosis.
Lechtzin N; Lange DJ; Davey C; Becker B; Mitsumoto H
Muscle Nerve; 2007 Jan; 35(1):98-102. PubMed ID: 17029274
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
